The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2744|54|10|1172-1180

ISSN: 0899-1987

Source: Molecular Carcinogenesis, Vol.54, Iss.10, 2015-10, pp. : 1172-1180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract